Mankind Pharma: India Business to Recover, BSV Integration on Track. Maintain ADD
Mankind Pharma (Mankind) has witnessed a moderation in its India business in 9MFY25 to single digits (~9% YoY ex-BSV) from mid-double-digit growth...
235 Views
Mankind Pharma Lock-Up - A US$1.1bn+ Lockup Release
The two pre-IPO investors have launched a block to sell around US$591m worth of Mankind Pharma shares. Since the lockup on the shares expired not...
794 Views
Mankind Pharma Pre-IPO - Peer Comparison - One of the Largest, with Better Growth and Margins
Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we will undertake a peer comparison.
574 Views
Mankind Pharma - Operationally In-Line; Outshines Industry in Chronic Category
Mankind Pharma (Mankind) delivered in-line operational performance for 3QFY25. The earnings were below estimates due to higher interest outgo on...
214 Views
Aequitas 2023 IPOs and Placements Performance Review - IPOs Forming a Low Base, Placements Pick Up
2023 was our eight year of covering Asia ECM. We ended 2023 with an accuracy rate of 73.7% across 57 IPOs that we covered and 79.3% across 115...
711 Views